Helping to close the loop on glycaemic control
Kaye is a 60-year-old woman with a highly demanding job as a CEO. She was diagnosed with type 1 diabetes at age 54 and started…
Kaye is a 60-year-old woman with a highly demanding job as a CEO. She was diagnosed with type 1 diabetes at age 54 and started…
Josh is a 26-year-old accountant diagnosed with type 1 diabetes six months ago after presenting to hospital with diabetic ketoacidosis. Josh has no other known…
Missing two basal or four bolus insulin doses in a fortnight is linked with a clinically significant >5% decrease in time with glucose levels in…
Geoff, a 79-year-old retiree, is a long-term aged care resident. The nursing staff report that he has had a red rash in both axillae for…
Diabetes is the most common cause of kidney failure (37% non-Indigenous Australians; 69% Indigenous Australians) and around 50% of people with type 2 diabetes (T2DM)…
Patients with types 1 diabetes will continue to have subsidised access to fast-acting insulin, with the approval of a new product to replace Fiasp and…
The Federal Government says fast-acting insulin products Fiasp and Fiasp FlexTouch will be subsidised for patients with type 1 diabetes for an extra six months…
A GP who taught dozens of his own patients with type 1 diabetes to build unapproved medical devices to manage their condition says a new…
Kiwi research has shown the use of DIY automated insulin delivery could help patients with type 1 diabetes stay in their target glucose range for…
Diabetes mellitus is globally endemic and is one of the leading causes of blindness in adults. Diabetes may cause macrovascular disease, microvascular complications, neuropathy and…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.